{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:52:18Z","timestamp":1790009538371,"version":"4.0.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"crossref","award":["215515\/Z\/19\/Z"],"award-info":[{"award-number":["215515\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p><jats:italic>Shigella<\/jats:italic> is a major diarrheal pathogen for which there is presently no vaccine. Whole genome sequencing provides the ability to predict and derive novel antigens for use as vaccines. Here, we aimed to identify novel immunogenic <jats:italic>Shigella<\/jats:italic> antigens that could serve as <jats:italic>Shigella<\/jats:italic> vaccine candidates, either alone, or when conjugated to <jats:italic>Shigella<\/jats:italic> O-antigen.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Using a reverse vaccinology approach, where genomic analysis informed the <jats:italic>Shigella<\/jats:italic> immunome via an antigen microarray, we aimed to identify novel immunogenic <jats:italic>Shigella<\/jats:italic> antigens. A core genome analysis of <jats:italic>Shigella<\/jats:italic> species, pathogenic and non-pathogenic <jats:italic>Escherichia coli<\/jats:italic>, led to the selection of 234 predicted immunogenic <jats:italic>Shigella<\/jats:italic> antigens. These antigens were expressed and probed with acute and convalescent serum from microbiologically confirmed <jats:italic>Shigella<\/jats:italic> infections.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Several <jats:italic>Shigella<\/jats:italic> antigens displayed IgG and IgA seroconversion, with no difference in sero-reactivity across by sex or age. IgG sero-reactivity to key <jats:italic>Shigella<\/jats:italic> antigens was observed at birth, indicating transplacental antibody transfer. Six antigens (FepA, EmrK, FhuA, MdtA, NlpB, and CjrA) were identified in in vivo testing as capable of producing binding IgG and complement-mediated bactericidal antibody.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These findings provide six novel immunogenic <jats:italic>Shigella<\/jats:italic> proteins that could serve as candidate vaccine antigens, species-specific carrier proteins, or targeted adjuvants.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13073-020-00824-4","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T14:02:43Z","timestamp":1610719363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The identification of novel immunogenic antigens as potential Shigella vaccine components"],"prefix":"10.1186","volume":"13","author":[{"given":"Ruklanthi","family":"de Alwis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Taghavian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao Chung","family":"The","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trang Nguyen Hoang","family":"Thu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vu Thuy","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Huw","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip L.","family":"Felgner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1308-5755","authenticated-orcid":false,"given":"Stephen","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"issue":"10122","key":"824_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0140-6736(17)33296-8","volume":"391","author":"KL Kotloff","year":"2018","unstructured":"Kotloff KL, Riddle MS, Platts-Mills JA, Pavlinac P, Zaidi AKM. Shigellosis. Lancet. 2018;391(10122):801\u201312.","journal-title":"Lancet"},{"issue":"11","key":"824_CR2","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/S1473-3099(18)30475-4","volume":"18","author":"IA Khalil","year":"2018","unstructured":"Khalil IA, Troeger C, Blacker BF, Rao PC, Brown A, Atherly DE, et al. Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016. Lancet Infect Dis. 2018;18(11):1229\u201340.","journal-title":"Lancet Infect Dis"},{"key":"824_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40794-018-0077-1","volume":"5","author":"S Olson","year":"2019","unstructured":"Olson S, Hall A, Riddle MS, Porter CK. Travelers\u2019 diarrhea: update on the incidence, etiology and risk in military and similar populations - 1990-2005 versus 2005-2015, does a decade make a difference? Tropical Diseases Travel Med Vaccines. 2019;5:1.","journal-title":"Tropical Diseases Travel Med Vaccines"},{"issue":"3","key":"824_CR4","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.1016\/S2214-109X(18)30483-2","volume":"7","author":"JD Anderson","year":"2019","unstructured":"Anderson JD, Bagamian KH, Muhib F, Amaya MP, Laytner LA, Wierzba T, et al. Burden of enterotoxigenic Escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis. Lancet Glob Health. 2019;7(3):e321\u2013e30.","journal-title":"Lancet Glob Health"},{"issue":"6390","key":"824_CR5","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1126\/science.aar3777","volume":"360","author":"S Baker","year":"2018","unstructured":"Baker S, Thomson N, Weill FX, Holt KE. Genomic insights into the emergence and spread of antimicrobial-resistant bacterial pathogens. Science. 2018;360(6390):733\u20138.","journal-title":"Science."},{"issue":"1","key":"824_CR6","first-page":"29","volume":"5","author":"M Mokomane","year":"2018","unstructured":"Mokomane M, Kasvosve I, de Melo E, Pernica JM, Goldfarb DM. The global problem of childhood diarrhoeal diseases: emerging strategies in prevention and management. Ther Adv Infect Dis. 2018;5(1):29\u201343.","journal-title":"Ther Adv Infect Dis"},{"issue":"1","key":"824_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1745-4565.2001.tb00307.x","volume":"21","author":"MH KOTHARY","year":"2001","unstructured":"KOTHARY MH, BABU US. Infective dose of foodborne pathogens in volunteers: a review. J Food Saf. 2001;21(1):49\u201368.","journal-title":"J Food Saf"},{"issue":"6","key":"824_CR8","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1128\/JCM.02713-12","volume":"51","author":"B Lindsay","year":"2013","unstructured":"Lindsay B, Ochieng JB, Ikumapayi UN, Toure A, Ahmed D, Li S, et al. Quantitative PCR for detection of Shigella improves ascertainment of Shigella burden in children with moderate-to-severe diarrhea in low-income countries. J Clin Microbiol. 2013;51(6):1740\u20136.","journal-title":"J Clin Microbiol"},{"issue":"12","key":"824_CR9","doi-asserted-by":"publisher","first-page":"e1309","DOI":"10.1016\/S2214-109X(18)30349-8","volume":"6","author":"JA Platts-Mills","year":"2018","unstructured":"Platts-Mills JA, Liu J, Rogawski ET, Kabir F, Lertsethtakarn P, Siguas M, et al. Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings: a reanalysis of the MAL-ED cohort study. Lancet Glob Health. 2018;6(12):e1309\u2013e18.","journal-title":"Lancet Glob Health"},{"issue":"26","key":"824_CR10","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1016\/j.vaccine.2016.02.075","volume":"34","author":"S Mani","year":"2016","unstructured":"Mani S, Wierzba T, Walker RI. Status of vaccine research and development for Shigella. Vaccine. 2016;34(26):2887\u201394.","journal-title":"Vaccine."},{"issue":"5","key":"824_CR11","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/infdis\/157.5.1068","volume":"157","author":"D Cohen","year":"1988","unstructured":"Cohen D, Green MS, Block C, Rouach T, Ofek I. Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population. J Infect Dis. 1988;157(5):1068\u201371.","journal-title":"J Infect Dis"},{"issue":"2","key":"824_CR12","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1128\/jcm.29.2.386-389.1991","volume":"29","author":"D Cohen","year":"1991","unstructured":"Cohen D, Green MS, Block C, Slepon R, Ofek I. Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis. J Clin Microbiol. 1991;29(2):386\u20139.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"824_CR13","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1080\/21645515.2019.1606971","volume":"15","author":"D Cohen","year":"2019","unstructured":"Cohen D, Meron-Sudai S, Bialik A, Asato V, Goren S, Ariel-Cohen O, et al. Serum IgG antibodies to Shigella lipopolysaccharide antigens - a correlate of protection against shigellosis. Hum Vaccin Immunother. 2019;15(6):1401\u20138.","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"824_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.clim.2011.02.003","volume":"139","author":"JK Simon","year":"2011","unstructured":"Simon JK, Maciel M Jr, Weld ED, Wahid R, Pasetti MF, Picking WL, et al. Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates. Clin Immunol. 2011;139(2):185\u201392.","journal-title":"Clin Immunol"},{"key":"824_CR15","doi-asserted-by":"crossref","unstructured":"Ndungo E, Randall A, Hazen TH, Kania DA, Trappl-Kimmons K, Liang X, et al. A novel Shigella proteome microarray discriminates targets of human antibody reactivity following oral vaccination and experimental challenge. mSphere. 2018;3(4):e00260-18.","DOI":"10.1128\/mSphere.00260-18"},{"issue":"7","key":"824_CR16","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrmicro1662","volume":"5","author":"MM Levine","year":"2007","unstructured":"Levine MM, Kotloff KL, Barry EM, Pasetti MF, Sztein MB. Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Nat Rev Microbiol. 2007;5(7):540\u201353.","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"824_CR17","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/cid\/ciu468","volume":"59","author":"S Livio","year":"2014","unstructured":"Livio S, Strockbine NA, Panchalingam S, Tennant SM, Barry EM, Marohn ME, et al. Shigella isolates from the global enteric multicenter study inform vaccine development. Clin Infect Dis. 2014;59(7):933\u201341.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"824_CR18","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1586\/14760584.5.5.669","volume":"5","author":"MM Venkatesan","year":"2006","unstructured":"Venkatesan MM, Ranallo RT. Live-attenuated Shigella vaccines. Expert Rev Vaccines. 2006;5(5):669\u201386.","journal-title":"Expert Rev Vaccines"},{"issue":"12","key":"824_CR19","doi-asserted-by":"publisher","first-page":"8027","DOI":"10.1128\/IAI.73.12.8027-8032.2005","volume":"73","author":"N Orr","year":"2005","unstructured":"Orr N, Katz DE, Atsmon J, Radu P, Yavzori M, Halperin T, et al. Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteers. Infect Immun. 2005;73(12):8027\u201332.","journal-title":"Infect Immun"},{"issue":"6","key":"824_CR20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.4161\/hv.4746","volume":"3","author":"KL Kotloff","year":"2007","unstructured":"Kotloff KL, Simon JK, Pasetti MF, Sztein MB, Wooden SL, Livio S, et al. Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media. Hum Vaccin. 2007;3(6):268\u201375.","journal-title":"Hum Vaccin"},{"issue":"3","key":"824_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ijmm.2013.01.001","volume":"303","author":"MN Dharmasena","year":"2013","unstructured":"Dharmasena MN, Hanisch BW, Wai TT, Kopecko DJ. Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a. Int J Med Microbiol. 2013;303(3):105\u201313.","journal-title":"Int J Med Microbiol"},{"issue":"3","key":"824_CR22","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1128\/CVI.00683-13","volume":"21","author":"RW Kaminski","year":"2014","unstructured":"Kaminski RW, Wu M, Turbyfill KR, Clarkson K, Tai B, Bourgeois AL, et al. Development and preclinical evaluation of a trivalent, formalin-inactivated Shigella whole-cell vaccine. Clin Vaccine Immunol. 2014;21(3):366\u201382.","journal-title":"Clin Vaccine Immunol"},{"issue":"18","key":"824_CR23","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1016\/j.vaccine.2005.07.014","volume":"24","author":"R McKenzie","year":"2006","unstructured":"McKenzie R, Walker RI, Nabors GS, Van De Verg LL, Carpenter C, Gomes G, et al. Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a phase I trial. Vaccine. 2006;24(18):3735\u201345.","journal-title":"Vaccine."},{"issue":"9","key":"824_CR24","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1073\/pnas.96.9.5194","volume":"96","author":"V Pozsgay","year":"1999","unstructured":"Pozsgay V, Chu C, Pannell L, Wolfe J, Robbins JB, Schneerson R. Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1. Proc Natl Acad Sci U S A. 1999;96(9):5194\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"824_CR25","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.vaccine.2009.12.050","volume":"28","author":"JH Passwell","year":"2010","unstructured":"Passwell JH, Ashkenazi S, Banet-Levi Y, Ramon-Saraf R, Farzam N, Lerner-Geva L, et al. Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children. Vaccine. 2010;28(10):2231\u20135.","journal-title":"Vaccine."},{"issue":"37","key":"824_CR26","doi-asserted-by":"publisher","first-page":"4990","DOI":"10.1016\/j.vaccine.2017.07.070","volume":"35","author":"N Farzam","year":"2017","unstructured":"Farzam N, Ramon-Saraf R, Banet-Levi Y, Lerner-Geva L, Ashkenazi S, Kubler-Kielb J, et al. Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice. Vaccine. 2017;35(37):4990\u20136.","journal-title":"Vaccine."},{"key":"824_CR27","doi-asserted-by":"crossref","unstructured":"Rappuoli R. Glycoconjugate vaccines: principles and mechanisms. Sci Transl Med. 2018;10(456):eaat4615.","DOI":"10.1126\/scitranslmed.aat4615"},{"issue":"3","key":"824_CR28","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1128\/IAI.69.3.1351-1357.2001","volume":"69","author":"JH Passwell","year":"2001","unstructured":"Passwell JH, Harlev E, Ashkenazi S, Chu C, Miron D, Ramon R, et al. Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel. Infect Immun. 2001;69(3):1351\u20137.","journal-title":"Infect Immun"},{"issue":"19","key":"824_CR29","doi-asserted-by":"publisher","first-page":"7974","DOI":"10.1073\/pnas.0900891106","volume":"106","author":"JB Robbins","year":"2009","unstructured":"Robbins JB, Kubler-Kielb J, Vinogradov E, Mocca C, Pozsgay V, Shiloach J, et al. Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates. Proc Natl Acad Sci U S A. 2009;106(19):7974\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 2","key":"824_CR30","doi-asserted-by":"publisher","first-page":"B87","DOI":"10.1016\/j.vaccine.2012.01.033","volume":"30","author":"D Serruto","year":"2012","unstructured":"Serruto D, Bottomley MJ, Ram S, Giuliani MM, Rappuoli R. The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens. Vaccine. 2012;30(Suppl 2):B87\u201397.","journal-title":"Vaccine."},{"issue":"1","key":"824_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40265-013-0155-7","volume":"74","author":"M O'Ryan","year":"2014","unstructured":"O'Ryan M, Stoddard J, Toneatto D, Wassil J, Dull PM. A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development program. Drugs. 2014;74(1):15\u201330.","journal-title":"Drugs."},{"issue":"4","key":"824_CR32","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.immuni.2010.09.017","volume":"33","author":"A Sette","year":"2010","unstructured":"Sette A, Rappuoli R. Reverse vaccinology: developing vaccines in the era of genomics. Immunity. 2010;33(4):530\u201341.","journal-title":"Immunity."},{"issue":"5","key":"824_CR33","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nbt.2197","volume":"30","author":"BF Haynes","year":"2012","unstructured":"Haynes BF, Kelsoe G, Harrison SC, Kepler TB. B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study. Nat Biotechnol. 2012;30(5):423\u201333.","journal-title":"Nat Biotechnol"},{"issue":"12","key":"824_CR34","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nrmicro2893","volume":"10","author":"PR Dormitzer","year":"2012","unstructured":"Dormitzer PR, Grandi G, Rappuoli R. Structural vaccinology starts to deliver. Nat Rev Microbiol. 2012;10(12):807\u201313.","journal-title":"Nat Rev Microbiol."},{"issue":"4","key":"824_CR35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1084\/jem.20151960","volume":"213","author":"R Rappuoli","year":"2016","unstructured":"Rappuoli R, Bottomley MJ, D'Oro U, Finco O, De Gregorio E. Reverse vaccinology 2.0: human immunology instructs vaccine antigen design. J Exp Med. 2016;213(4):469\u201381.","journal-title":"J Exp Med"},{"key":"824_CR36","doi-asserted-by":"crossref","unstructured":"Anders KL, Thompson CN, Thuy NT, Nguyet NM, Tu le TP, Dung TT, et al. The epidemiology and aetiology of diarrhoeal disease in infancy in southern Vietnam: a birth cohort study. Int J Infect Dis 2015;35:3\u201310.","DOI":"10.1016\/j.ijid.2015.03.013"},{"key":"824_CR37","doi-asserted-by":"crossref","unstructured":"Duong VT, Tuyen HT, Minh PV, Campbell J, Phuc HL, Nhu TDH, et al. No clinical benefit of empirical antimicrobial therapy for pediatric diarrhea in a high-usage, high-resistance setting. Clin Infect Dis. 2017; cix844.","DOI":"10.1093\/cid\/cix844"},{"key":"824_CR38","doi-asserted-by":"crossref","unstructured":"Thompson CN, Anders KL, Nhi le TQ, Tuyen HT, Van Minh P, Tu le TP, et al. A cohort study to define the age-specific incidence and risk factors of Shigella diarrhoeal infections in Vietnamese children: a study protocol BMC Public Health 2014;14:1289.","DOI":"10.1186\/1471-2458-14-1289"},{"issue":"6","key":"824_CR39","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.vaccine.2015.12.047","volume":"34","author":"CN Thompson","year":"2016","unstructured":"Thompson CN, Le TP, Anders KL, Nguyen TH, Lu LV, Nguyen VV, et al. The transfer and decay of maternal antibody against Shigella sonnei in a longitudinal cohort of Vietnamese infants. Vaccine. 2016;34(6):783\u201390.","journal-title":"Vaccine."},{"issue":"4","key":"824_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060120","volume":"8","author":"T Vesth","year":"2013","unstructured":"Vesth T, Lagesen K, Acar O, Ussery D. CMG-biotools, a free workbench for basic comparative microbial genomics. PLoS One. 2013;8(4):e60120.","journal-title":"PLoS One"},{"issue":"Database issue","key":"824_CR41","first-page":"D281","volume":"36","author":"RD Finn","year":"2008","unstructured":"Finn RD, Tate J, Mistry J, Coggill PC, Sammut SJ, Hotz HR, et al. The Pfam protein families database. Nucleic Acids Res. 2008;36(Database issue):D281\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"824_CR42","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1006\/jmbi.2000.4315","volume":"305","author":"A Krogh","year":"2001","unstructured":"Krogh A, Larsson B, von Heijne G, Sonnhammer EL. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol. 2001;305(3):567\u201380.","journal-title":"J Mol Biol"},{"key":"824_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-1-4939-7015-5_6","volume":"1611","author":"H Nielsen","year":"2017","unstructured":"Nielsen H. Predicting secretory proteins with SignalP. Methods Mol Biol. 2017;1611:59\u201373.","journal-title":"Methods Mol Biol"},{"issue":"3","key":"824_CR44","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1073\/pnas.0408782102","volume":"102","author":"DH Davies","year":"2005","unstructured":"Davies DH, Liang X, Hernandez JE, Randall A, Hirst S, Mu Y, et al. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc Natl Acad Sci U S A. 2005;102(3):547\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"824_CR45","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1093\/infdis\/jiy312","volume":"218","author":"S Chakraborty","year":"2018","unstructured":"Chakraborty S, Randall A, Vickers TJ, Molina D, Harro CD, DeNearing B, et al. Human experimental challenge with enterotoxigenic Escherichia coli elicits immune responses to canonical and novel antigens relevant to vaccine development. J Infect Dis. 2018;218(9):1436\u201346.","journal-title":"J Infect Dis"},{"key":"824_CR46","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/srep01043","volume":"3","author":"L Liang","year":"2013","unstructured":"Liang L, Juarez S, Nga TV, Dunstan S, Nakajima-Sasaki R, Davies DH, et al. Immune profiling with a Salmonella Typhi antigen microarray identifies new diagnostic biomarkers of human typhoid. Sci Rep. 2013;3:1043.","journal-title":"Sci Rep"},{"issue":"Web Server issu","key":"824_CR47","doi-asserted-by":"publisher","first-page":"W553","DOI":"10.1093\/nar\/gks420","volume":"40","author":"MA Kayala","year":"2012","unstructured":"Kayala MA, Baldi P. Cyber-T web server: differential analysis of high-throughput data. Nucleic Acids Res. 2012;40(Web Server issue):W553\u20139.","journal-title":"Nucleic Acids Res"},{"key":"824_CR48","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511541773","volume-title":"DNA microarrays and gene expression: from experiments to data analysis and modeling: Cambridge University Press","author":"P Baldi","year":"2002","unstructured":"Baldi P, Hatfield GW. DNA microarrays and gene expression: from experiments to data analysis and modeling: Cambridge University Press; 2002."},{"key":"824_CR49","unstructured":"Baldi P, Brunak SR. Bioinformatics: the machine learning approach, 2nd Edition. Bach F, editor: MIT Press; 2001."},{"key":"824_CR50","doi-asserted-by":"crossref","unstructured":"Y. B, Y. H. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 1995;57(1):289\u2013300.","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"},{"issue":"3","key":"824_CR51","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1128\/IAI.03079-14","volume":"83","author":"S Rondini","year":"2015","unstructured":"Rondini S, Micoli F, Lanzilao L, Gavini M, Alfini R, Brandt C, et al. Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium. Infect Immun. 2015;83(3):996\u20131007.","journal-title":"Infect Immun"},{"key":"824_CR52","doi-asserted-by":"crossref","unstructured":"de Alwis R, Tu LTP, Quynh NLT, Thompson CN, Anders KL, Van Thuy NT, et al. The role of maternally acquired antibody in providing protective immunity against nontyphoidal Salmonella in urban Vietnamese infants: a birth cohort study. J Infect Dis. 2019;219(2):295-304.","DOI":"10.1093\/infdis\/jiy501"},{"key":"824_CR53","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fcimb.2017.00064","volume":"7","author":"E Mattock","year":"2017","unstructured":"Mattock E, Blocker AJ. How do the virulence factors of Shigella work together to cause disease? Front Cell Infect Microbiol. 2017;7:64.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"824_CR54","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4049\/immunohorizons.1700057","volume":"2","author":"GG Fouda","year":"2018","unstructured":"Fouda GG, Martinez DR, Swamy GK, Permar SR. The impact of IgG transplacental transfer on early life immunity. Immunohorizons. 2018;2(1):14\u201325.","journal-title":"Immunohorizons."},{"issue":"3","key":"824_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004749","volume":"11","author":"M Caboni","year":"2015","unstructured":"Caboni M, Pedron T, Rossi O, Goulding D, Pickard D, Citiulo F, et al. An O antigen capsule modulates bacterial pathogenesis in Shigella sonnei. PLoS Pathog. 2015;11(3):e1004749.","journal-title":"PLoS Pathog"},{"key":"824_CR56","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fcimb.2016.00018","volume":"6","author":"Y Wei","year":"2016","unstructured":"Wei Y, Murphy ER. Shigella iron acquisition systems and their regulation. Front Cell Infect Microbiol. 2016;6:18.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"824_CR57","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S0014-5793(02)03185-X","volume":"529","author":"V Braun","year":"2002","unstructured":"Braun V, Braun M. Iron transport and signaling in Escherichia coli. FEBS Lett. 2002;529(1):78\u201385.","journal-title":"FEBS Lett"},{"issue":"13","key":"824_CR58","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1128\/JB.183.13.3958-3966.2001","volume":"183","author":"D Smajs","year":"2001","unstructured":"Smajs D, Weinstock GM. The iron- and temperature-regulated cjrBC genes of Shigella and enteroinvasive Escherichia coli strains code for colicin Js uptake. J Bacteriol. 2001;183(13):3958\u201366.","journal-title":"J Bacteriol"},{"issue":"1","key":"824_CR59","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1038\/s41598-019-39749-3","volume":"9","author":"M Pasqua","year":"2019","unstructured":"Pasqua M, Grossi M, Scinicariello S, Aussel L, Barras F, Colonna B, et al. The MFS efflux pump EmrKY contributes to the survival of Shigella within macrophages. Sci Rep. 2019;9(1):2906.","journal-title":"Sci Rep"},{"issue":"15","key":"824_CR60","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1128\/JB.184.15.4161-4167.2002","volume":"184","author":"S Nagakubo","year":"2002","unstructured":"Nagakubo S, Nishino K, Hirata T, Yamaguchi A. The putative response regulator BaeR stimulates multidrug resistance of Escherichia coli via a novel multidrug exporter system. MdtABC J Bacteriol. 2002;184(15):4161\u20137.","journal-title":"MdtABC J Bacteriol"},{"key":"824_CR61","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1471-2180-11-147","volume":"11","author":"S Kuntumalla","year":"2011","unstructured":"Kuntumalla S, Zhang Q, Braisted JC, Fleischmann RD, Peterson SN, Donohue-Rolfe A, et al. In vivo versus in vitro protein abundance analysis of Shigella dysenteriae type 1 reveals changes in the expression of proteins involved in virulence, stress and energy metabolism. BMC Microbiol. 2011;11:147.","journal-title":"BMC Microbiol"},{"issue":"2","key":"824_CR62","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2005.02.015","volume":"121","author":"T Wu","year":"2005","unstructured":"Wu T, Malinverni J, Ruiz N, Kim S, Silhavy TJ, Kahne D. Identification of a multicomponent complex required for outer membrane biogenesis in Escherichia coli. Cell. 2005;121(2):235\u201345.","journal-title":"Cell."},{"issue":"27","key":"824_CR63","doi-asserted-by":"publisher","first-page":"E3574","DOI":"10.1073\/pnas.1501049112","volume":"112","author":"KE Holt","year":"2015","unstructured":"Holt KE, Wertheim H, Zadoks RN, Baker S, Whitehouse CA, Dance D, et al. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci U S A. 2015;112(27):E3574\u201381.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5690","key":"824_CR64","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1126\/science.1099930","volume":"305","author":"EP Skaar","year":"2004","unstructured":"Skaar EP, Humayun M, Bae T, DeBord KL, Schneewind O. Iron-source preference of Staphylococcus aureus infections. Science. 2004;305(5690):1626\u20138.","journal-title":"Science."},{"issue":"2","key":"824_CR65","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1128\/JCM.00640-11","volume":"50","author":"BH Mao","year":"2012","unstructured":"Mao BH, Chang YF, Scaria J, Chang CC, Chou LW, Tien N, et al. Identification of Escherichia coli genes associated with urinary tract infections. J Clin Microbiol. 2012;50(2):449\u201356.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"824_CR66","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1128\/MMBR.00031-09","volume":"74","author":"TN Ellis","year":"2010","unstructured":"Ellis TN, Kuehn MJ. Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev. 2010;74(1):81\u201394.","journal-title":"Microbiol Mol Biol Rev"},{"key":"824_CR67","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fimmu.2019.00335","volume":"10","author":"O Launay","year":"2019","unstructured":"Launay O, Ndiaye AGW, Conti V, Loulergue P, Scire AS, Landre AM, et al. Booster vaccination with GVGH Shigella sonnei 1790GAHB GMMA vaccine compared to single vaccination in unvaccinated healthy European adults: results from a phase 1 clinical trial. Front Immunol. 2019;10:335.","journal-title":"Front Immunol"},{"issue":"2","key":"824_CR68","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ijmm.2015.12.003","volume":"306","author":"L Maggiore","year":"2016","unstructured":"Maggiore L, Yu L, Omasits U, Rossi O, Dougan G, Thomson NR, et al. Quantitative proteomic analysis of Shigella flexneri and Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) reveals highly pure preparations. Int J Med Microbiol. 2016;306(2):99\u2013108.","journal-title":"Int J Med Microbiol."},{"issue":"9","key":"824_CR69","doi-asserted-by":"publisher","first-page":"5879","DOI":"10.4049\/jimmunol.0901838","volume":"183","author":"S Boullier","year":"2009","unstructured":"Boullier S, Tanguy M, Kadaoui KA, Caubet C, Sansonetti P, Corthesy B, et al. Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits. J Immunol. 2009;183(9):5879\u201385.","journal-title":"J Immunol"},{"issue":"8","key":"824_CR70","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1128\/IAI.00303-13","volume":"81","author":"A Mathias","year":"2013","unstructured":"Mathias A, Longet S, Corthesy B. Agglutinating secretory IgA preserves intestinal epithelial cell integrity during apical infection by Shigella flexneri. Infect Immun. 2013;81(8):3027\u201334.","journal-title":"Infect Immun"},{"issue":"6","key":"824_CR71","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1080\/21645515.2019.1606972","volume":"15","author":"LA Barel","year":"2019","unstructured":"Barel LA, Mulard LA. Classical and novel strategies to develop a Shigella glycoconjugate vaccine: from concept to efficacy in human. Hum Vaccin Immunother. 2019;15(6):1338\u201356.","journal-title":"Hum Vaccin Immunother."},{"key":"824_CR72","doi-asserted-by":"publisher","unstructured":"de Alwis R, and Baker S. The identification of novel immunogenic antigens as potential Shigella vaccine components (version 1). Zenodo. https:\/\/doi.org\/10.5281\/zenodo.4320935 (2020).","DOI":"10.5281\/zenodo.4320935"}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-020-00824-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-020-00824-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-020-00824-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T05:01:07Z","timestamp":1674882067000},"score":1,"resource":{"primary":{"URL":"https:\/\/genomemedicine.biomedcentral.com\/articles\/10.1186\/s13073-020-00824-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["824"],"URL":"https:\/\/doi.org\/10.1186\/s13073-020-00824-4","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,15]]},"assertion":[{"value":"8 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Human serum samples for the purposes of this investigation were collected from an observational study of children with diarrheal disease and a cohort study of healthy infants, both conducted in Ho Chi Minh City (HCMC), Vietnam. The observational study that collected acute and convalescent blood samples from pediatric diarrheal patients was approved by the institutional review boards (IRB) of three local hospitals in HCMC and the Oxford Tropical Research Ethics Committee (OxTREC No. 1045-13) in the UK. Written informed consent by a legal guardian was obtained prior to enrolment into this observational study. The pediatric cohort study from which the current investigation accessed umbilical cord blood was approved by the local IRB of four local hospitals in HCMC and OxTREC (No. 02-09). Written informed consent was obtained from pregnant mothers prior to enrolment into the cohort. This study conforms to the ethical guidelines of the Helsinki Declaration. All animal work for this study was conducted by GenScript Biotech Corporation under the auditing, monitoring, and approval of GenScript\u2019s Institutional Animal Care and Use Committee (IACUC).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}